- Geopolitical Concerns Keep Oil Supported near $144
- South Korea Won Jumps on Intervention Warning
- Asian Markets Are Mixed, Shanghai Leads
- Will Smith Tops Box Office with 'Hancock'
- NBC Universal to Buy The Weather Channel
- Merrill Will Decide on BlackRock Stake Sale Soon
- For Stocks, Escaping Bear Hinges on Oil, GE
- Bush Backs Strong Dollar Policy
- Merrill May Be Close to Selling Bloomberg Stake: Report
- The Week: Pickers Focus on Steel, Financials, Tech & International Stocks
- Bowyer: Back to Monarchy in Land Rights?
- Parking Cash in European Telecoms
- Bargain Stocks: Nokia, Spectra, Incitex Pivot
- Sticker Shock: Fast Money's Inflation Special
- Our Favorite Inflation Trades
- Warren Buffett's Annual Stock Gift to Gates Foundation Worth $1.8B This Year
- That '70's Trade
- The Villain Of Our Story
Merck and Eli Lilly reported earnings today, and CNBC asked the pharmaceutical companies’ chief executives and an analyst to discuss the results and the sector as a whole.
Eli Lilly CEO: Q1 Bodes Well
"We're in the business of bringing new medicines to the market that, obviously, have to compete effectively with generics. I think the kind of growth we saw this first quarter indicates that we've been able to do that."
- John Lechleiter, CEO of Eli Lilly [LLY
Loading...
()
]
Merck CEO: Look Deeper
“Although we missed slightly on the top line, the underlying growth and new products are doing extremely well for the company in the first quarter…
When you look at our strategy for the company, we have to leverage the cost expenses that we had during the year in order to make sure if you have challenges, that you’re able to offset those.”
- Richard Clark, CEO of Merck [MRK
Loading...
()
]
Betting on the Pharma Sector
“Our favorite stock is Merck, and the other stock we’re recommending is Bristol-Myers [BMY
Loading...
()
], which I think is going to benefit from strength in their existing product portfolio, as well as a major restructuring initiative.”
- Barbara Ryan, Deutsche Bank
Print
Email
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes